lemtrada 12 mg concentrate for solution for infusion
genzyme therapeutics ltd - alemtuzumab - concentrate for solution for infusion - 12 mg alemtuzumab in 1.2 ml (10 mg/ml) - multiple sclerosis - selective immunosuppressants - indicated for adult patients with relapsing remitting multiple sclerosis (rrms) with active disease defined by clinical or imaging features
mabcampath solution
genzyme corporation - alemtuzumab - solution - 10mg - alemtuzumab 10mg - antineoplastic agents
thyrogen 1,1 mg/ vial (0,9 mg/ml) polvo liofilizado para solucion inyectable i.m.
hospira inc. de estados unidos, acond. sec. genzyme corporation de estados unidos - tirotropina alfa - tirotropina alfa....1.1 mg
mabcampath
genzyme europe b.v. - alemtuzumab - leukemia, lymphocytic, chronic, b-cell - antineoplastic agents - mabcampath is indicated for the treatment of patients with b-cell chronic lymphocytic leukaemia (bcll) for whom fludarabine combination chemotherapy is not appropriate.
fabrazyme ® 35mg (agalsidase beta)
sanofi-aventis singapore pte. ltd. - agalsidase beta - injection, powder, for solution - 37.0mg/35mg vial - agalsidase beta 37.0mg/35mg vial
fabrazyme ® 5mg (agalsidase beta)
sanofi-aventis singapore pte. ltd. - agalsidase beta - injection, powder, for solution - 5.5mg/5mg vial - agalsidase beta 5.5mg/5mg vial
cerezyme® (imiglucerase) 400u powder for solution for injection
sanofi-aventis singapore pte. ltd. - imiglucerase - injection, powder, for solution - 424 u - imiglucerase 424 u
thyrogen 0.9 mg powder for solution for injection
sanofi-aventis singapore pte. ltd. - thyrotropin alfa - injection, powder, for solution - 1.1 mg - thyrotropin alfa 1.1 mg
mozobil 24mg/1.2ml solution for injection
genzyme europe b.v., netherlands - plerixafor - solution for injection - 20 mg/ml
sevelamer hydrochloride winthrop sevelamer hydrochloride 400 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer hydrochloride -